- Home
- CHEB vs LUCD Comparison
CHEB vs LUCD Comparison
Compare CHEB & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHEB
- LUCD
- Stock Information
- Founded
- CHEB 2024
- LUCD 2018
- Country
- CHEB Singapore
- LUCD United States
- Employees
- CHEB N/A
- LUCD N/A
- Industry
- CHEB
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CHEB
- LUCD Health Care
- Exchange
- CHEB NYSE
- LUCD Nasdaq
- Market Cap
- CHEB 122.8M
- LUCD 135.6M
- IPO Year
- CHEB 2024
- LUCD 2021
- Fundamental
- Price
- CHEB $10.45
- LUCD $1.13
- Analyst Decision
- CHEB
- LUCD Strong Buy
- Analyst Count
- CHEB 0
- LUCD 4
- Target Price
- CHEB N/A
- LUCD $3.88
- AVG Volume (30 Days)
- CHEB 50.2K
- LUCD 971.5K
- Earning Date
- CHEB 01-01-0001
- LUCD 05-14-2025
- Dividend Yield
- CHEB N/A
- LUCD N/A
- EPS Growth
- CHEB N/A
- LUCD N/A
- EPS
- CHEB N/A
- LUCD N/A
- Revenue
- CHEB N/A
- LUCD $4,346,000.00
- Revenue This Year
- CHEB N/A
- LUCD $107.75
- Revenue Next Year
- CHEB N/A
- LUCD $231.37
- P/E Ratio
- CHEB N/A
- LUCD N/A
- Revenue Growth
- CHEB N/A
- LUCD 79.00
- 52 Week Low
- CHEB $9.30
- LUCD $0.63
- 52 Week High
- CHEB $26.25
- LUCD $1.80
- Technical
- Relative Strength Index (RSI)
- CHEB N/A
- LUCD 36.90
- Support Level
- CHEB N/A
- LUCD $1.19
- Resistance Level
- CHEB N/A
- LUCD $1.24
- Average True Range (ATR)
- CHEB 0.00
- LUCD 0.07
- MACD
- CHEB 0.00
- LUCD -0.01
- Stochastic Oscillator
- CHEB 0.00
- LUCD 4.17
About CHEB CHENGHE ACQUISITION II CO
Chenghe Acquisition II Co is a blank check company.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.